“Chronic Conditions”

34 result(s)
Care Management
Next-generation Transform Diabetes Care addresses five high-impact clinical areas to provide comprehensive support for members with diabetes, including differentiated glucometer... More
Briefing
Care Management
Pharmacy Advisor provides personalized support for people on long-term therapies, helping them uncover and resolve adherence issues and obstacles for improved condition management. More
Briefing
Care Management
Health Advisor uses a wealth of data and advanced analytics to develop a personalized care plan and communicate member-specific next best actions that will improve outcomes and... More
Briefing
Care Management
While we are all dealing with a changed world. Our evolving approach using groundbreaking data analysis and innovative touchpoints can help transform chronic care, and reflects a... More
Commentary
Specialty
AccordantCare offers a range of digital tools that have been proven to improve member engagement and outcomes, as well as a nurse-led care management model that ensures ongoing... More
Briefing
Cost Management
Our new RxZERO plan design fordiabetes eliminates member out-of-pocket costs, and enables clients to help membersimprove health outcomes without raising premiums or deductibles More
White Paper
Care Management
CVS Health can help Medicare plan sponsors achieve high quality ratings by focusing on key measures such as medication adherence and gaps in care. More
Briefing
Specialty
CareTeams with clinical expertise and digital tools including secure messaging, apps, and wearables help improve outcomes for patients with complex or rare conditions. More
Briefing
Specialty
Patients who have rare or complex conditions benefit from personalized, in-depth care management from a team of specially trained nurses, pharmacists, social workers and... More
Briefing
Innovation
CVS Health is expanding its Project Health campaign to target more underserved and underinsured communities in 2019. Nearly 600 free screening events will take place in 12 markets... More
Commentary